Biofourmis

Biofourmis is reinventing remote patient monitoring by detecting personalized patterns predictive of patient’s health deterioration

Biofourmis is a fast-growing global digital HealthTech start-up that is reinventing remote patient monitoring to bring this extremely demanding goal within reach. By harnessing the power of artificial intelligence, they’re advancing the practice of medicine by detecting personalized patterns predictive of patient’s health deterioration. Named as “Top 20 Hottest Start-ups in Singapore” by Singapore Business Review and Asia’s most Innovative Start-up by Galen Growth Asia, Singapore, their team is powered by the passion of their mission to improve the lives of cardiac patients and those that care for them. Biofourmis was founded by scientists, and cardiologists in September 2015, focused on combining clinicians’ knowledge of biological mechanism that drives the human body and diseases and advanced machine learning techniques to enable the machine to find personalized patterns predictive of patient’s health deterioration. Biofourmis has built biovitalsTM, the most sophisticated personalized physiological data analytics engine based on human physiology that formulates personalized health models, resulting in highly optimised post-acute patient monitoring solutions and accurate prediction of patient health deterioration before it happens. They use connected devices and bio-sensors to capture physiological signals and detect anomalies. This AI-empowered continuous monitoring platform alerts medical professionals to intervene days before a critical event. This technological-enabled integrated care delivery allows for remote communication, diagnosis, monitoring, ​and intervention. The dual-edged diagnostic precision and early-intervention results in improved health outcomes and lower healthcare costs.